Skip To Main Content
Helena Bleken Østergaard on Muck Rack

Helena Bleken Østergaard

As seen in: Wiley Online Library, Diabetes Care Magazine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Helena Bleken

Contact Helena Bleken, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Development and Validation of a Lifetime Risk Model for Kidney Failure and Treatment Benefit in Type 2 Diabetes

|
By Helena Bleken Østergaard, Stephanie Read, Naveed Sattar, Stefan Franzen
Thank you for your help in sharing the high-quality science in CJASN. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. Message Subject (Your Name) has sent you a message from American Society of Nephrology Message Body (Your Name) thought you would like to see the American Society of Nephrology web site. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Open in Who Shared View Duplicates (270) Issue with article?

Cardiovascular risk and lifetime benefit from preventive treatment in type 2 diabetes: a post hoc analysis of the CAPTURE study

|
By Helena Bleken Østergaard, Valerie Humphreys, Ellen Margo Hengeveld
| Wiley Online Library Verified
Abstract Aim CAPTURE was a non-interventional, cross-sectional, multinational study collecting clinical characteristics on 9823 adults with type 2 diabetes, aiming to estimate cardiovascular disease (CVD) prevalence and treatment patterns. This post hoc analysis aimed to assess gain in life-years free of (recurrent) CVD event with optimal cardiovascular risk management (CVRM) and initiation of glucose-lowering agents with proven cardiovascular benefit.
Open in Who Shared Issue with article?

Comment on Vistisen et al. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes. Diabetes Care 2021;44:901-907

|
By Frank L.J. Visseren, Jan Westerink, Franciscus Gasthuis, Helena Bleken Østergaard
| Diabetes Care Magazine Verified
e-Letters: Comments and Responses Helena Bleken Østergaard1, Joep van der Leeuw2,3, Frank L.J. Visseren1 and Jan Westerink1⇑ 1Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, the Netherlands 2Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, the Netherlands 3Department of Nephrology, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands Corresponding author: Jan Westerink, j.westerink-3{at}umcutrecht.nl With great interest...
Open in Who Shared Issue with article?
See all 3 articles